These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30475452)

  • 1. An ultrasound-responsive dual-modal US/T
    Yoon YI; Ha SW; Lee HJ
    J Magn Reson Imaging; 2018 Dec; 48(6):1610-1616. PubMed ID: 30475452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative [Fe]MRI determination of the dynamics of PSMA-targeted SPIONs discriminates among prostate tumor xenografts based on their PSMA expression.
    Sillerud LO
    J Magn Reson Imaging; 2018 Aug; 48(2):469-481. PubMed ID: 29331081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels.
    Sillerud LO
    Int J Nanomedicine; 2016; 11():357-71. PubMed ID: 26855574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular MR Imaging of Prostate Cancer by Specified Iron Oxide Nanoparticles With PSMA-11 Peptides: A Preclinical Study.
    Ghorbani F; Aminzadeh B; Borji N; Soudmand S; Montazerabadi A
    J Magn Reson Imaging; 2024 Jun; 59(6):2204-2214. PubMed ID: 37572082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents.
    Sanna V; Pintus G; Bandiera P; Anedda R; Punzoni S; Sanna B; Migaleddu V; Uzzau S; Sechi M
    Mol Pharm; 2011 Jun; 8(3):748-57. PubMed ID: 21545176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided Therapy.
    Ngen EJ; Benham Azad B; Boinapally S; Lisok A; Brummet M; Jacob D; Pomper MG; Banerjee SR
    Mol Pharm; 2019 May; 16(5):2060-2068. PubMed ID: 30912947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.
    Pu F; Salarian M; Xue S; Qiao J; Feng J; Tan S; Patel A; Li X; Mamouni K; Hekmatyar K; Zou J; Wu D; Yang JJ
    Nanoscale; 2016 Jul; 8(25):12668-82. PubMed ID: 26961235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner.
    Taylor RM; Sillerud LO
    Int J Nanomedicine; 2012; 7():4341-52. PubMed ID: 22915856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
    Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
    J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of microbubbles as contrast agents for ultrasonography and magnetic resonance imaging.
    Li L; Wei Q; Li HB; Wen S; Teng GJ
    PLoS One; 2012; 7(4):e34644. PubMed ID: 22506039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
    Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
    Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles.
    Zhu Y; Sun Y; Chen Y; Liu W; Jiang J; Guan W; Zhang Z; Duan Y
    Int J Mol Sci; 2015 Apr; 16(5):9573-87. PubMed ID: 25927579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
    Li X; Xia S; Zhou W; Ji R; Zhan W
    Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging.
    Sun J; Li X; Chen A; Cai W; Peng X; Li L; Fan B; Wang L; Zhang H; Zhang R
    Int J Nanomedicine; 2019; 14():9893-9904. PubMed ID: 31908447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer.
    Tse BW; Cowin GJ; Soekmadji C; Jovanovic L; Vasireddy RS; Ling MT; Khatri A; Liu T; Thierry B; Russell PJ
    Nanomedicine (Lond); 2015 Feb; 10(3):375-86. PubMed ID: 25407827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles.
    Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K
    Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles.
    Xiao N; Gu W; Wang H; Deng Y; Shi X; Ye L
    J Colloid Interface Sci; 2014 Mar; 417():159-65. PubMed ID: 24407672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine and Nitrogen Co-Doped Carbon Dot Complexation with Fe(III) as a T
    Wang J; Hu X; Ding H; Huang X; Xu M; Li Z; Wang D; Yan X; Lu Y; Xu Y; Chen Y; Morais PC; Tian Y; Zhang RQ; Bi H
    ACS Appl Mater Interfaces; 2019 May; 11(20):18203-18212. PubMed ID: 31026133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA.
    Wang Y; De Leon AC; Perera R; Abenojar E; Gopalakrishnan R; Basilion JP; Wang X; Exner AA
    Sci Rep; 2021 Feb; 11(1):4726. PubMed ID: 33633232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.